title: Risks and benefits of weaning immunosuppression in liver transplant recipients: long-term follow-up.
authors.affiliation: Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pennsylvania 15213, USA.
authors.forename: G V
authors.initials: GV
authors.lastname: Mazariegos
authors.forename: J
authors.initials: J
authors.lastname: Reyes
authors.forename: I
authors.initials: I
authors.lastname: Marino
authors.forename: B
authors.initials: B
authors.lastname: Flynn
authors.forename: J J
authors.initials: JJ
authors.lastname: Fung
authors.forename: T E
authors.initials: TE
authors.lastname: Starzl
mesh_terms: D002648:Child; D015331:Cohort Studies; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects / Q000379:methods*; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D016031:Liver Transplantation / Q000276:immunology* / Q000502:physiology; D011183:Postoperative Complications / Q000453:epidemiology*; D013997:Time Factors
chemical_list: D007166:Immunosuppressive Agents